Summary
- Current Price
- As of today, AKBA price is $0.91, down -1.39% on
- Current Price All-Time High
- AKBA price is currently -97.08% below its historical high of $31.00 set on
- Market Cap
- AKBA current market cap is $251M, down -70.06% year-over-year
- Revenue
- AKBA current annual revenue is $236.20M, up +47.46% year-over-year
- Next Earnings
- The next earnings release for AKBA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Akebia Therapeutics, Inc. |
| Ticker | NASDAQ: AKBA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | akebia.com |
| Employees | 181 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $0.91 | |
| Price, 1D Change | -1.39% | |
| $251M | ||
| - | ||
| - | ||
| 1.12 | ||
| $236.20M | ||
| Revenue, 1Y Change | +47.46% | |
| -$0.02 | ||
| EPS, 1Y Change | +93.68% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.02 | ||
| EPS Estimate | -$0.13 | N/A |
| EPS Est. Change | -525.00% | N/A |
| $236.20M | ||
| Revenue Estimate | $197.95M | N/A |
| Revenue Est. Change | -16.19% | N/A |
| Current Price | $0.91 | |
| Price Target | $4.00 | - |
| Price Tgt. Change | +341.21% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.26 | -$0.33 | -26.54% | |
| -$0.04 | -$0.02 | +48.00% | |
| -$0.13 | N/A | -525.00% | |
| -$0.20 | N/A | -861.54% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $151.05M | $160.18M | +6.05% | |
| $231.52M | $236.20M | +2.02% | |
| $197.95M | N/A | -16.19% | |
| $148.19M | N/A | -37.26% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $0.91 | |
| $1.34 | ||
| $1.14 | ||
| $1.44 | ||
| $1.11 | ||
| -$0.10 | ||
| 1.12 | ||
| $0.07 | ||
| 36.00 | ||
| 55.73% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $236.20M | ||
| -$0.02 | ||
| $0.00 | ||
| 82.76% | ||
| $23.50M | ||
| 9.95% | ||
| -$5.35M | ||
| -2.26% | ||
| $24.77M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 6.63 | ||
| 1.55 | ||
| 1.46 | ||
| - | ||
| 3 | ||
| -4.91 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 1.15 | ||
| 10.04 | ||
| -26.21 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $32.61M | ||
| $186.54M | ||
| $376.57M | ||
| $252.96M | ||
| $343.96M | ||
| $162.94M | ||
| $216.30M | ||
| $40.08M | ||
| $21.19M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $241.54M | ||
| $171.97M | ||
| $40.73M | ||
| $110.88M | ||
| $1.27M | ||
| $0.00 | ||
| $1.62M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $67.99M | ||
| -$7.93M | ||
| $72.93M | ||
| $291.00K | ||
| $67.70M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Leerink Partners | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| BTIG | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
Screeners with AKBA
FAQ
- What is the ticker symbol for Akebia Therapeutics, Inc.?
- The ticker symbol for Akebia Therapeutics, Inc. is NASDAQ:AKBA
- Does Akebia Therapeutics, Inc. pay dividends?
- No, Akebia Therapeutics, Inc. does not pay dividends
- What sector is Akebia Therapeutics, Inc. in?
- Akebia Therapeutics, Inc. is in the Healthcare sector
- What industry is Akebia Therapeutics, Inc. in?
- Akebia Therapeutics, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Akebia Therapeutics, Inc. based in?
- Akebia Therapeutics, Inc. is headquartered in United States
- When did Akebia Therapeutics, Inc. go public?
- Akebia Therapeutics, Inc. initial public offering (IPO) was on March 20, 2014
- Is Akebia Therapeutics, Inc. in the S&P 500?
- No, Akebia Therapeutics, Inc. is not included in the S&P 500 index
- Is Akebia Therapeutics, Inc. in the NASDAQ 100?
- No, Akebia Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Akebia Therapeutics, Inc. in the Dow Jones?
- No, Akebia Therapeutics, Inc. is not included in the Dow Jones index
- When was Akebia Therapeutics, Inc. last earnings report?
- Akebia Therapeutics, Inc.'s most recent earnings report was on August 5, 2026
- When does Akebia Therapeutics, Inc. report earnings?
- The next expected earnings date for Akebia Therapeutics, Inc. is November 9, 2026
Data Sources & References
- AKBA Official Website www.akebia.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1517022/000151702226000020/0001517022-26-000020-index.htm
- AKBA Profile on Yahoo Finance finance.yahoo.com/quote/AKBA
- AKBA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/akba